ArticleCell death & disease2023

Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia.

Chendi Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.